MedTrace Logo

SupporTive Care At Home Research for Patients With Advanced Cancer (STAHR-cancer)

NCT05636384 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 396

Last updated 2022-12-05

No results posted yet for this study

Summary

To test the effects of home-based care on unplanned hospitalization within 6 months among advanced cancer patients with decreased performance status. Home-based care includes education for patients and their family caregivers, home visits by specialized home-based medical staff, and regular status check-ups.

Conditions

  • Malignant Neoplasm
  • Home Care Services
  • Quality of LIfe
  • Unplanned Hospitalization

Interventions

OTHER

Home-based care

Home-based medical care is based on a specialized home-based medical team approach, including following: 1. Specialized Home-Based Medical Team Approach 2. Initial Assessment and Education 3. Initial Home Visits and Education 4. Multidisciplinary Team Meeting 5. Regular Assessment After the Initial Visit

Sponsors & Collaborators

  • Chung-Ang University Hosptial, Chung-Ang University College of Medicine

    collaborator OTHER

  • DongGuk University

    collaborator OTHER

  • Kyung Hee University Hospital

    collaborator OTHER

  • Bundang CHA Hospital

    collaborator OTHER

  • Seoul National University Bundang Hospital

    collaborator OTHER

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Belong Cho, MD, MPH, PhD · Seoul National University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-25
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05636384 on ClinicalTrials.gov